DUBLIN--(BUSINESS WIRE)--The "Contrast Media Agent and Injector System Market - A Global and Regional Analysis: Focus on Product and Country Analysis - Analysis and Forecast, 2022-2026" report has ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has launched Gadoterate Meglumine Injection, USP, a bioequivalent and therapeutic equivalent substitute for the contrast agent ...

Factors such as the growing prevalence of cancer and CVD; a large number of approvals for contrast agents; and increasing investments, funds, and grants by government organizations are driving the ...

CHICAGO, Sept. 2, 2020 /PRNewswire/ -- According to the new market research report "Contrast Media Injectors Market By Product (Injector Systems (CT Injector, MRI Injector), Consumables (Syringes), ...

Contrast Injectors Market Report Overview. Key Market Players and Market Shares. Report Overview:[126 Pages Report] The contrast injectors market is projected to reach USD 2.4 billion by 2024 from USD ...

Although contrast agents have an essential role in non-invasive imaging techniques, potential side effects limit their use. For example, both low- and iso-osmolar iodinated contrast media used in ...

Open label, randomized, phase II study of pertuzumab (P) in patients (pts) with metastatic breast cancer (MBC) with low expression of HER2 No significant financial relationships to disclose. This is ...